See all locations for this study
Phase 2Recruiting

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Sponsored by Sparrow Pharmaceuticals

About this study

CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol. Participants deemed eligible from Part 1 will be randomized to either clofutriben or placebo in the double-blind (participant and investigator), dose-ranging, interventional Part 2 (Treatment).

Enrolling at this location

Emory University School of Medicine

Dallas, Texas

This location is no longer enrolling. Other locations for this study may still be open.

See all locations

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.